Cargando…

Editorial: Immune intervention avenues to control fungal infections in immunocompromised individuals

Detalles Bibliográficos
Autor principal:	Nanjappa, Som G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10546402/ https://www.ncbi.nlm.nih.gov/pubmed/37795078 http://dx.doi.org/10.3389/fimmu.2023.1212797

Ejemplares similares

T cell responses to control fungal infection in an immunological memory lens
por: Sharma, Jaishree, et al.
Publicado: (2022)

267. Fungal Culture Diagnostic Stewardship: An Avenue for Antimicrobial Stewardship in the Immunocompromised Host
por: Gurram, Pooja, et al.
Publicado: (2019)

Editorial: Immune Surveillance of the HIV Reservoir: Mechanisms, Therapeutic Targeting and New Avenues for HIV Cure
por: Prado, Julia G., et al.
Publicado: (2020)

Cellular Immunity Is Critical for Assessing COVID-19 Vaccine Effectiveness in Immunocompromised Individuals
por: Paramithiotis, Eustache, et al.
Publicado: (2022)

Editorial: The Immunology of Sepsis—Understanding Host Susceptibility, Pathogenesis of Disease, and Avenues for Future Treatment
por: Schlapbach, Luregn J., et al.
Publicado: (2020)

Editorial: Immunity to Human Fungal Pathogens: Mechanisms of Host Recognition, Protection, Pathology, and Fungal Interference
por: Templeton, Steven P., et al.
Publicado: (2018)

Editorial: Immunological Memory to Fungal Infections and Vaccine Development
por: Nicola, André Moraes, et al.
Publicado: (2022)

Emerging fungal infections in immunocompromised patients
por: Low, Chian-Yong, et al.
Publicado: (2011)

Cutaneous fungal infection in an immunocompromised host
por: Sotello, David, et al.
Publicado: (2017)

Succinylation modification provides new insights for the treatment of immunocompromised individuals with drug-resistant Aspergillus fumigatus infection
por: Chen, Xianzhen, et al.
Publicado: (2023)

Metabolic Checkpoints: Novel Avenues for Immunotherapy of Cancer
por: Shevchenko, Ivan, et al.
Publicado: (2018)

Editorial: Innate immune responses to SARS-CoV-2 in infected and vaccinated individuals
por: Saksena, Nitin K., et al.
Publicado: (2023)

NK cell subsets and dysfunction during viral infection: a new avenue for therapeutics?
por: Bjorgen, Jacob C., et al.
Publicado: (2023)

Emerging viral infections in immunocompromised patients: A great challenge to better define the role of immune response
por: Agrati, Chiara, et al.
Publicado: (2023)

Immune Interaction Map of Human SARS-CoV-2 Target Genes: Implications for Therapeutic Avenues
por: Subbarayan, Karthikeyan, et al.
Publicado: (2021)

Human Perforin Employs Different Avenues to Damage Membranes
por: Praper, Tilen, et al.
Publicado: (2011)

miR-aculous new avenues for cancer immunotherapy
por: Tang, William W., et al.
Publicado: (2022)

The immune responses to different Uropathogens call individual interventions for bladder infection
por: Li, Linlong, et al.
Publicado: (2022)

Tc17 Cells Mediate Vaccine Immunity against Lethal Fungal Pneumonia in Immune Deficient Hosts Lacking CD4(+) T Cells
por: Nanjappa, Som Gowda, et al.
Publicado: (2012)

Editorial: Circadian Control of Immunity
por: Ikuta, Koichi, et al.
Publicado: (2020)

GM-CSF(+) Tc17 cells are required to bolster vaccine immunity against lethal fungal pneumonia without causing overt pathology
por: Mudalagiriyappa, Srinivasu, et al.
Publicado: (2022)

New Avenues to Design Toxoplasma Vaccines Based on Oocysts and Cysts
por: Arranz-Solís, David, et al.
Publicado: (2022)

CD160 receptor in CLL: Current state and future avenues
por: Oumeslakht, Loubna, et al.
Publicado: (2022)

Editorial: Immunity to Parasitic Infections in Pregnancy
por: Doritchamou, Justin Y. A., et al.
Publicado: (2021)

Fungal Infections of the Ear in Immunocompromised Host: a Review
por: Viswanatha, Borlingegowda, et al.
Publicado: (2011)

Challenges in the Diagnosis of Invasive Fungal Infections in Immunocompromised Hosts
por: Antinori, Spinello, et al.
Publicado: (2018)

Invasive fungal infection by Peziza ostracoderma in an immunocompromised patient
por: Kinch, Amelie, et al.
Publicado: (2022)

Editorial: Immune Control of JC Virus Infection and Immune Failure during Progressive Multifocal Leukoencephalopathy
por: Taoufik, Yassine, et al.
Publicado: (2017)

Dermatophyte infection: from fungal pathogenicity to host immune responses
por: Deng, Ruixin, et al.
Publicado: (2023)

Factors that predict severity of infection and seroconversion in immunocompromised children and adolescents with COVID-19 infection
por: Abu Shanap, Mayada, et al.
Publicado: (2022)

Editorial: Immune regulation and intervention in virus-related tumor development
por: Mo, Qinglin, et al.
Publicado: (2023)

Editorial: Emerging Viruses: Host Immunity and Novel Therapeutic Interventions
por: Smed-Sörensen, Anna, et al.
Publicado: (2018)

Editorial: Structural and Computational Glycobiology – Immunity and Infection
por: Agostino, Mark, et al.
Publicado: (2015)

Pulmonary Talcosis in an Immunocompromised Patient
por: Nguyen, Thanh-Phuong, et al.
Publicado: (2016)

Toxoplasma gondii infection in immunocompromised individuals
por: Csep, Andrei, et al.
Publicado: (2013)

Virus-Specific T Cells for the Immunocompromised Patient
por: Houghtelin, Amy, et al.
Publicado: (2017)

Editorial: Host and Pathogen Determinants of Allergic and Invasive Fungal Diseases
por: Obar, Joshua J., et al.
Publicado: (2020)

Editorial: Innate immune responses in HIV controllers
por: Thobakgale, Christina, et al.
Publicado: (2023)

Editorial: Genetic and Epigenetic Control of Immune Responses
por: Noonepalle, Satish kumar R., et al.
Publicado: (2021)

Editorial: Exploring Immune Variability in Susceptibility to Tuberculosis Infection in Humans
por: Seshadri, Chetan, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_io2hgup28r7g8gvforseqtakh3